Ardent Health Inc (ARDT) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Ardent Health Inc   (NYSE: ARDT)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Ardent Health Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Ardent Health Inc's ROI in the second quarter of 2026?
Ardent Health Inc achieved a return on average invested assets (ROI) of 3.95 % in its second quarter of 2026, which is below Ardent Health Inc's average return on investment, which stands at 7.49%.

ROI decreased relative to the period ending Mar 31 2026, due to the decline in net income.

Within the Healthcare sector 6 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 813 to 1317.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 5.63 % 7.63 % 8.15 % 44.1 % 115.28 %
Y / Y Net Income Change TTM -50.63 % -26.59 % -9.34 % 162.7 % 410.09 %
Investment (TTM) in Millions 4,304 4,301 4,244 4,211 4,146
Return On Investment (TTM) 3.95 % 5.43 % 5.52 % 7.22 % 8.46 %
ARDT's Overall Ranking # 1317 # 813 # 806 # 834 #
Seq. Investment Change TTM 0.93 % 1.32 % 1.42 % 1.85 % 2.84 %
Seq. Net Income Change TTM -26.57 % -0.21 % -22.45 % -13.12 % 9.19 %
Net Income (TTM) in Millions 169 230 230 297 342




Return On Investment ARDT's Ranking
Within: No.
Industry # 0
Sector # 7
Overall # 1317

Return On Investment Statistics
High Average Low
9.07 %
7.49 %
6.25 %
(Jun 30 2025)   (Mar 31 2026)







Financial Statements
Ardent Health Inc's II. Quarter Investments $ 4,304 Millions ARDT's Balance sheet
Ardent Health Inc's II. Quarter Income $ 35 Millions Quarterly ARDT's Income Statement
ARDT's Income by Division See ARDT's Income by Division


ARDT Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024



Total Investments in Millions 4,244 4,011 0 0 0
Y / Y Investment Growth 5.81 % - - - -
Net Income in Millions 230 300 0 0 0
Y / Y Net Income Growth -23.21 % - - - -
Annual Return On Investment 5.42 % 7.47 % - - -


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 5.42 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ARDT's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ARDT's Competitors
Subscribers only: Roi for Ardent Health Inc's Suppliers
Subscribers only: Return On Investment for ARDT's Customers

Other Ratios
ARDT's Roa ARDT's Inventory Turnover Ratio ARDT's Growth Rates ARDT's Dividend Statistics
ARDT's Profitability Ratios ARDT's Asset Turnover Ratio ARDT's Dividend Growth
ARDT's Roe ARDT's Valuation Ratios ARDT's Financial Strength Ratios ARDT's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Bioventus Inc   10.85 %
Infusystem Holdings Inc  10.53 %
Livanova Plc  10.40 %
Beone Medicines Ltd   10.32 %
Entrada Therapeutics Inc   10.15 %
Jazz Pharmaceuticals Plc  10.06 %
Prestige Consumer Healthcare Inc   10.06 %
Tactile Systems Technology Inc   10.02 %
Tenet Healthcare Corp  9.98 %
Nature s Sunshine Products inc   9.91 %
Boston Scientific Corporation  9.91 %
Align Technology inc   9.50 %
Pediatrix Medical Group Inc   9.18 %
Abbvie Inc   9.11 %
Ani Pharmaceuticals Inc  9.09 %
Viemed Healthcare Inc   8.97 %
Stryker Corp  8.80 %
Penumbra Inc  8.71 %
Utah Medical Products Inc  8.70 %
Edwards Lifesciences Corporation  8.39 %
Veracyte Inc   8.15 %
Phibro Animal Health Corporation  8.11 %
Brightspring Health Services Inc   8.05 %
Quest Diagnostics Inc  8.05 %
Addus Homecare Corp  7.98 %
Corcept Therapeutics Inc  7.96 %
Amneal Pharmaceuticals Inc   7.91 %
Concentra Group Holdings Parent Inc   7.89 %
Bio techne Corp  7.61 %
Pacific Health Care Organization Inc  7.42 %


Date modified: 2026-08-13T04:05:25+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.